Potential of Orally Administered Quercetin, Hesperidin, and p-Coumaric Acid in Suppressing Intra-/Extracellular Advanced Glycation End-Product-Induced Cytotoxicity in Proximal Tubular Epithelial Cells

  • 0Division of Molecular and Genetic Biology, Department of Life Science, Medical Research Institute, Kanazawa Medical University, Uchinada 920-0293, Ishikawa, Japan.

|

|

Summary

This summary is machine-generated.

Japanese folk medicine compounds like quercetin and hesperidin may protect kidney cells from damage caused by advanced glycation end-products (AGEs). These compounds and p-coumaric acid show potential in preventing AGE-related kidney dysfunction.

Area Of Science

  • Nephrology
  • Pharmacology
  • Natural Products Chemistry

Background

  • Advanced glycation end-products (AGEs) contribute to proximal tubular epithelial (PTE) cell dysfunction in lifestyle diseases.
  • Urinary stones cause cytotoxicity in PTE cells, necessitating therapeutic interventions.
  • Japanese folk medicine utilizes *Quercus salicina*/*Q. stenophylla* leaves, known to contain bioactive compounds.

Purpose Of The Study

  • To review the effects of quercetin, hesperidin, and p-coumaric acid on PTE cells.
  • To investigate the metabolism of these compounds after oral administration.
  • To explore their role in mitigating AGE-induced cytotoxicity and generation in PTE cells.

Main Methods

  • Literature review of existing preclinical and clinical studies.
  • Analysis of metabolic pathways of quercetin, hesperidin, and p-coumaric acid.
  • Assessment of their impact on AGEs and PTE cell cytotoxicity.

Main Results

  • Non-metabolized quercetin and p-coumaric acid may suppress AGE-induced cytotoxicity in PTE cells.
  • Metabolites of quercetin and hesperidin show potential in inhibiting AGE generation.
  • The combined effect of these compounds may offer collective protection against AGEs in PTE cells.

Conclusions

  • Quercetin, hesperidin, and p-coumaric acid from *Q. salicina*/*Q. stenophylla* show promise in managing AGE-related PTE cell damage.
  • Further preclinical and clinical research is warranted to validate these findings.
  • Understanding the metabolism of these compounds is crucial for therapeutic development.